Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with СOVID-19: Ukrainian experience.

Autopsy Coronavirus infection Diffuse alveolar damage Ground glass opacity SARS-CoV-2

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
May 2023
Historique:
received: 10 02 2023
revised: 18 04 2023
accepted: 18 04 2023
medline: 15 5 2023
pubmed: 28 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on lung tissue in patients on respiratory support is of significant scientific interest in predicting mortality. This study aimed to analyze post-mortem histological changes in the lung tissue of COVID-19 patients on respiratory support using vital radiology semiotics. A total of 41 autopsies were performed on patients who died of SARS-CoV-2 and had confirmed COVID-19 by polymerase chain reaction (PCR) and radiological evidence of lung tissue consolidation and ground glass opacity. The results showed that the duration of COVID-19 in patients on respiratory support was significantly associated with the development of all stages of diffuse alveolar damage, acute fibrous organizing pneumonia, pulmonary capillary congestion, fibrin thrombi, perivascular inflammation, alveolar hemorrhage, proliferating interstitial fibroblasts, and pulmonary embolism. The prediction model for lethal outcomes based on the duration of total respiratory support had a sensitivity of 68.3% and a specificity of 87.5%. In conclusion, for COVID-19 patients on long-term respiratory support with radiological signs of ground glass opacity and lung consolidation, post-mortem morphological features included various stages of diffuse alveolar lung damage, pulmonary capillary congestion, fibrin clots, and perivascular inflammation.

Identifiants

pubmed: 37104960
pii: S0344-0338(23)00171-1
doi: 10.1016/j.prp.2023.154471
pmc: PMC10122962
pii:
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154471

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Viktoriya Matskevych (V)

Department of Radiology and Radiation Medicine, Ivano-Frankivsk National Medical University, Ukraine.

Olexandr Kamyshnyi (O)

Department of Microbiology, Virology and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.

Volodymyr M Vasylyk (VM)

Pathology Department, Municipal Non-profit Enterprise "Regional Clinical Hospital of Ivano-Frankivsk Regional Council", Ivano-Frankivsk, Ukraine.

Marta B Grynovska (MB)

Department of Anesthesiology and Intensive Care, Ivano-Frankivsk National Medical University, Ukraine.

Tetiana Lenchuk (T)

Department of Radiology and Radiation Medicine, Ivano-Frankivsk National Medical University, Ukraine.

Roman Fishchuk (R)

Clinical Trials Unit, Municipal Non-profit Enterprise "Ivano-Frankivsk Central City Hospital", Ukraine.

Dmytro Gospodaryov (D)

Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, Ukraine.

Ihor Yurkevych (I)

Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, Ukraine.

Olha Strilbytska (O)

Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, Ukraine.

Pavlo Petakh (P)

Department of Microbiology, Virology and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine; Department of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine. Electronic address: pavlo.petakh@uzhnu.edu.ua.

Oleh Lushchak (O)

Department of Biochemistry and Biotechnology, Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, Ukraine; Research and Development University, Ivano-Frankivsk, Ukraine. Electronic address: oleh.lushchak@pnu.edu.ua.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH